EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

U-73122, a phospholipase C inhibitor, impairs lymphocytic choriomeningitis virus virion infectivity

Keita Mizuma, Mei Hashizume, Shuzo Urata, Keiko Shindo, Ayako Takashima, Satoshi Mizuta, Masaharu Iwasaki

Journal of General Virology · 2024

DOI: 10.1099/jgv.0.002060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, 2024. Verfasst von Keita Mizuma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Emerging Viral Diseases, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka Univer…. Hauptthemen laut MEDLINE: Lymphocytic choriomeningitis virus, Antiviral Agents, Pyrrolidinones, Virus Replication. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, The Research Foundation for Microbial Diseases of Osaka University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lassa virus (LASV) is an Old World (OW) mammarenavirus that causes Lassa fever, a life-threatening acute febrile disease endemic in West Africa. Lymphocytic choriomeningitis virus (LCMV) is a worldwide-distributed, prototypic OW mammarenavirus of clinical significance that has been largely neglected as a human pathogen. No licensed OW mammarenavirus vaccines are available, and the current therapeutic option is limited to the off-label use of ribavirin, which offers only partial efficacy. This situation underscores the urgent need to develop novel antivirals against human pathogenic mammarenaviruses. Previously, we showed that afatinib, a pan-ErbB tyrosine kinase inhibitor, inhibited multiple steps of the life cycles of OW LASV and LCMV, as well as the New World Junín virus vaccine strain Candid#1. In the present study, we investigated the inhibitory effect of U-73122, a phospholipase C inhibitor that acts downstream of ErbB signalling, on LCMV multiplication. U-73122 inhibited WT recombinant (r) LCMV multiplication in cultured cells. Preincubation of cell-free LCMV virions with U-73122 resulted in impaired virion infectivity. U-73122 also inhibited the infection of rLCMVs expressing heterologous viral glycoproteins, including the vesicular stomatitis Indiana virus (VSIV) glycoprotein, whereas WT VSIV infection was not affected by U-73122 treatment. Our results show the novel bioactivity of U-73122 as an LCMV inhibitor and indicate the presence of a virion-associated molecule that is necessary for virion infectivity and can be exploited as a potential antiviral drug target against human pathogenic mammarenavirus infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytic choriomeningitis virusAntiviral AgentsPyrrolidinonesVirus ReplicationEstrenesAnimalsHumansChlorocebus aethiopsType C PhospholipasesVirionVero CellsCell LineLassa virus

Stichwörter der Autor:innen

Junín virusLCMVLassa virusantiviralvirion

Substanzen

Antiviral AgentsPyrrolidinones1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dioneEstrenesType C Phospholipases

Autor:innen und Institutionen

  • Laboratory of Emerging Viral Diseases, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Present address: Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.
  • National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki, Japan.
  • Center for Bioinformatics and Molecular Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
  • Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, Japan.
  • Center for Advanced Modalities and Drug Delivery System, Osaka University, Suita, Osaka, Japan.

Förderung

  • Japan Agency for Medical Research and Development
  • The Research Foundation for Microbial Diseases of Osaka University

Zitieren

APA

Mizuma, K., Hashizume, M., Urata, S., Shindo, K., Takashima, A., Mizuta, S., & Iwasaki, M. (2024). U-73122, a phospholipase C inhibitor, impairs lymphocytic choriomeningitis virus virion infectivity. Journal of General Virology. https://doi.org/10.1099/jgv.0.002060

Vancouver

Mizuma K, Hashizume M, Urata S, Shindo K, Takashima A, Mizuta S, et al. U-73122, a phospholipase C inhibitor, impairs lymphocytic choriomeningitis virus virion infectivity. Journal of General Virology. 2024. doi:10.1099/jgv.0.002060

BibTeX
@article{Mizuma2024,
  author = {Mizuma, Keita and Hashizume, Mei and Urata, Shuzo and Shindo, Keiko and Takashima, Ayako and Mizuta, Satoshi and Iwasaki, Masaharu},
  title = {U-73122, a phospholipase C inhibitor, impairs lymphocytic choriomeningitis virus virion infectivity},
  journal = {Journal of General Virology},
  year = {2024},
  doi = {10.1099/jgv.0.002060}
}
Kostenlos starten →